A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 555 shares of TMDX stock, worth $65,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
555
Previous 590 5.93%
Holding current value
$65,523
Previous $39,000 89.74%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$67.67 - $143.04 $2,368 - $5,006
-35 Reduced 5.93%
555 $74,000
Q1 2025

May 15, 2025

BUY
$56.73 - $79.42 $27,230 - $38,121
480 Added 436.36%
590 $39,000
Q4 2024

Feb 13, 2025

BUY
$59.28 - $144.9 $6,520 - $15,939
110 New
110 $6,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $3.76B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.